HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) saw a significant decline in short interest in December. As of December 30th, there was short interest totalling 3,900 shares, a decline of 40.0% from the December 15th total of 6,500 shares. Based on an average trading volume of 13,400 shares, the short-interest ratio is currently 0.3 days.
HAVN Life Sciences Price Performance
OTCMKTS:HAVLF traded up $0.05 during mid-day trading on Wednesday, hitting $0.10. 5,143 shares of the stock traded hands, compared to its average volume of 14,355. HAVN Life Sciences has a 12-month low of $0.00 and a 12-month high of $4.59. The business's 50-day moving average price is $0.06 and its 200 day moving average price is $0.37.
Get
HAVN Life Sciences alerts:
About HAVN Life Sciences
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.
Recommended Stories
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
- Can Alaska Air Continue Soaring Above The Airline Industry?
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
去年12月,HAvn Life Science Inc.(场外市场代码:HAVLF-GET Rating)的空头股数业务出现了大幅下滑。截至12月30日,空头股数共有3900股,比12月15日的6500股减少了40.0%。以平均成交量13,400股计算,目前短息比为0.3天。
拥有生命科学的性价比
OTCMKTS:HAVLF在周三午盘交易中上涨0.05美元,触及0.10美元。该股共有5,143股易手,而其平均成交量为14,355股。HAvn Life Sciences的股价为0.00美元,为12个月低点,12个月高位为4.59美元。该业务的50日移动均线价格为0.06美元,200日移动均线价格为0.37美元。
到达
拥有生命科学学位警报:
关于HAVN生命科学
(获取评级)
HAVN生命科学公司是一家生物技术公司,从事从植物和真菌中提取的精神药理产品的研究和开发。该公司还专注于开发从植物和真菌(包括裸子菌属)中标准化和质量控制地提取精神活性化合物的方法。
推荐故事
- 免费获取StockNews.com关于HAVN生命科学的研究报告(HAVLF)
- 如新控股股票与沃伦·巴菲特有什么关系?
- J.B.亨特买房,物流公司成为焦点
- 英特尔股票是否即将突破?
- 人们对百事可乐的新苏打水不感兴趣,这有什么关系吗?
- 阿拉斯加航空能否继续在航空业之上高歌猛进?
接受《HAVN生命科学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对HAVN生命科学和相关公司的最新新闻和分析师评级的每日简要摘要。